- Home
- MYO
MYO
Myomo Inc.
as 03-25-2025 1:31pm EST
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 178.4M | IPO Year: | 2017 |
| Target Price: | $9.75 | AVG Volume (30 days): | 625.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.51 - $7.17 | Next Earning Date: | 03-10-2025 |
| Revenue: | $32,551,198 | Revenue Growth: | 69.17% |
| Revenue Growth (this year): | 32.15% | Revenue Growth (next year): | 17.59% |
Stock Insider Trading Activity of Myomo Inc. (MYO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mitchell Micah | MYO | Chief Commercial Officer | Mar 14 '25 | Sell | $5.16 | 48,000 | $247,564.80 | 140,572 | |
| KIRK THOMAS F | MYO | Director | Mar 13 '25 | Buy | $5.00 | 7,400 | $37,000.00 | 255,933 | |
| Kovelman Harry | MYO | Chief Medical Officer | Mar 11 '25 | Sell | $5.50 | 30,000 | $165,018.00 | 97,973 |
Latest Myomo Inc. News
MYO Breaking Stock News: Dive into MYO Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
15 days ago
Q4 2024 Myomo Inc Earnings Call
GuruFocus.com
15 days ago
Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ...
Zacks
16 days ago
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
MT Newswires
16 days ago
Myomo Q4 Loss Narrows, Sales Rise; Sets Guidance
Business Wire
16 days ago
Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million
GuruFocus.com
19 days ago
What To Expect From Myomo Inc (MYO) Q4 2024 Earnings
Business Wire
23 days ago
Myomo to Report Fourth Quarter 2024 Financial Results on March 10
Zacks
a month ago
AdaptHealth Corp. (AHCO) Q4 Earnings and Revenues Surpass Estimates
Compare MYO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MYO Myomo Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.